PubMed Health⌕ Search

Biomedical subjects

J J Stablein

Publications and source records attributed to J J Stablein.

6 recordsLinked to original sources

A three-year aerobiologic pollen survey of the Tampa Bay area, Florida.

An aerobiologic survey using a rotoslide sampler was conducted daily (January 1979 through December 1981) in Tampa, Florida. A major tree pollen season (Dec. through May) consisted of oak, pine, Australian pine, bald cypress, cedar, bayberry and mulberry. A minor tree season (Oct. and Nov.) consisted of Australian pine and elm. Grass pollen was found throughout the year and most prevalent April through October. A major weed pollen season (May through Dec.) consisted of ragweed, Mexican tea, pigweed, dog fennel, and false nettle. A minor weed season (March through July) consisted of sorrel and dock.

Air Pollution↗

Pharmacokinetics and bioavailability of three dyphylline preparations.

The pharmacokinetics and bioavailability of 3 oral dyphylline preparations, solution (S), regular (R) and sustained release (SR), were studied in 8 healthy subjects (mean age 25 years). A single dose of each preparation, 20 mg X kg-1, was given at one week intervals and multiple serum samples obtained over 24 h. Drug levels were measured by high performance liquid chromatography. No adverse effects were found. The dyphylline half-life for the solution was 2.16 +/- 0.18 h and for the tablet 2.59 +/- 0.56 h. The mean clearance rate for S was 13.6 +/- 1.7 h-1 and volume of distribution 43.0 +/- 3.91. Peak concentration (Cmax, micrograms X ml-1), time of peak (Tmax, h), area under the curve (AUC, micrograms X ml-1 X h) and relative bioavailability (RB, %), were determined for three preparations: Cmax S, 33.7 +/- 3.7; R, 27.7 +/- 4.2; SR, 10.4 +/- 1.5 Tmax: S, 0.33 +/- 0.0; R, 0.66 +/- 0.0; SR, 2.13 +/- 1.1 AUC: S, 108.4 +/- 12.1; R, 113.9 +/- 25.2; SR, 104.0 +/- 30.8 RB: Reference Product R, 105.00 +/- 16.00; SR, 100.00 +/- 25.00 The data confirm the short half-life of dyphylline, demonstrate a lack of toxicity for the 20 mg X kg-1 dose and establish bioequivalence for the products studied.

Adult↗

Asthma improved by acetylsalicylic acid and other nonsteroidal anti-inflammatory agents.

Acetylsalicylic acid (ASA) and other nonsteroidal anti-inflammatory drugs (NSAID) cause a variety of symptoms in patients sensitive to these drugs. These include wheezing, rhinorrhea, flushing, pruritus, urticaria, hypotension and loss of consciousness. Conversely, improvement of asthma with the use of these drugs in patients who do not have idiosyncratic reactions to ASA (ASA-nonsensitive) has also been observed both with respect to clinical symptoms and pulmonary function tests.

Anti-Inflammatory Agents, Non-Steroidal↗